Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isoniazid Monoresistance and Antituberculosis Treatment Outcome in Persons With Pulmonary Tuberculosis in Brazil.
Araújo-Pereira M, Arriaga MB, Carvalho ACC, Spener-Gomes R, Schmaltz CAS, Nogueira BMF, Figueiredo MC, Turner MM, Cordeiro-Santos M, Rolla VC, Sterling TR, Andrade BB, Kritski AL; Regional Prospective Observational Research for Tuberculosis (RePORT)-Brazil Consortium. Araújo-Pereira M, et al. Among authors: carvalho acc. Open Forum Infect Dis. 2024 Jan 8;11(1):ofad691. doi: 10.1093/ofid/ofad691. eCollection 2024 Jan. Open Forum Infect Dis. 2024. PMID: 38221983 Free PMC article.
HIV infection in 567 active pulmonary tuberculosis patients in Brazil.
Kritski AL, Werneck-Barroso E, Vieira MA, Carvalho AC, Carvalho CE, Bravo-de-Souza R, Andrade Gde N, Galvao-Castro B, Castilho EA, Hearst N. Kritski AL, et al. J Acquir Immune Defic Syndr (1988). 1993 Sep;6(9):1008-12. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8340889
Determinants of losses in the tuberculosis infection cascade of care among children and adolescent contacts of pulmonary tuberculosis cases: A Brazilian multi-centre longitudinal study.
Sobral L, Arriaga MB, Souza AB, Araújo-Pereira M, Barreto-Duarte B, Sales C, Rocha MS, Benjamin A, Moreira ASR, de Oliveira JG, Carvalho AC, Spener-Gomes R, Figueiredo MC, Cavalcante S, Durovni B, Lapa-E-Silva JR, Kritski AL, Rolla VC, Sterling TR, Cordeiro-Santos M, Andrade BB. Sobral L, et al. Lancet Reg Health Am. 2022 Nov;15:100358. doi: 10.1016/j.lana.2022.100358. Epub 2022 Aug 23. Lancet Reg Health Am. 2022. PMID: 36438860 Free PMC article.
Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil.
Ridolfi F, Amorim G, Peetluk LS, Haas DW, Staats C, Araújo-Pereira M, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Rolla VC, Sterling TR; Regional Prospective Observational Research in Tuberculosis (RePORT)–Brazil Consortium. Ridolfi F, et al. J Infect Dis. 2024 Mar 14;229(3):813-823. doi: 10.1093/infdis/jiae025. J Infect Dis. 2024. PMID: 38262629
Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies.
Martinez L, Seddon JA, Horsburgh CR, Lange C, Mandalakas AM; TB Contact Studies Consortium. Martinez L, et al. Lancet Respir Med. 2024 May 8:S2213-2600(24)00083-3. doi: 10.1016/S2213-2600(24)00083-3. Online ahead of print. Lancet Respir Med. 2024. PMID: 38734022
196 results